HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Conference papers

Tolerance and efficacy of rituximab in primary Sjögren syndrome (TEARS): results of the randomized controlled trial.

Document type :
Conference papers
Complete list of metadata

https://hal.univ-brest.fr/hal-00783135
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Thursday, January 31, 2013 - 3:09:03 PM
Last modification on : Wednesday, April 27, 2022 - 4:03:42 AM

Identifiers

  • HAL Id : hal-00783135, version 1

Citation

Valérie Devauchelle-Pensec, Xavier Mariette, Sandrine Jousse-Joulin, Jean-Marie Berthelot, Aleth Perdriger, et al.. Tolerance and efficacy of rituximab in primary Sjögren syndrome (TEARS): results of the randomized controlled trial.. Congrès de l'EULAR,"The European League against Rheumatism Congress", Jun 2012, Berlin, Germany. pp.75. ⟨hal-00783135⟩

Share

Metrics

Record views

201